
Lunch Wrap: Tariff storm sinks ASX again, but Orthocell powers ahead with FDA approval
ASX hit hard, around $30 billion wiped off Wall street crashes, tech giants plummet, fear gauge soars Orthocell gets US FDA approval The ASX 200 took another big hit on Friday, down by 1.7% at lunch AEDT as the market erased a further $30 billion-ish …